Skip to main content

Table 4 Logistic regressions on goal/normal lipid level attainment

From: Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)

Dependent variable

 

Odds ratio

95% CI

TC

Age

1.02

1.01

1.03

 

Gender

0.89

0.78

1.01

 

T2DM

0.73

0.63

0.85

 

CHD

0.55

0.45

0.69

 

TC

0.93

0.92

0.93

 

Time on statin

0.85

0.83

0.87

LDL-C

Age

1.02

1.01

1.02

 

Gender

1.20

1.06

1.36

 

T2DM

0.65

0.56

0.75

 

CHD

0.42

0.34

0.53

 

LDL-C

0.93

0.92

0.94

 

Time on statin

0.86

0.84

0.88

TGs

Age

1.01

1.01

1.02

 

Gender

1.05

0.92

1.20

 

T2DM

0.73

0.63

0.86

 

TGs

0.84

0.84

0.85

 

Time on statin

0.94

0.92

0.97

HDL-C

Age

1.01

1.00

1.02

 

Gender

0.07

0.05

0.08

 

T2DM

0.70

0.58

0.83

 

HDL-C

2.15

2.06

2.25

 

Time on statin

1.02

0.99

1.05

  1. TC = total cholesterol, LDL-C = low-density lipoprotein, TG = triglycerides, HDL-C = high-density lipoprotein. The basic model included age and gender, BMI. Smoking, hypertension, baseline lipid values, history of diabetes, history of CHD and time on statin therapy (years). Insignificant variables were then stepwise excluded. Age, gender and time on statin are considered important to keep in model even if non significant in some models. Gender: Male = 1 (Female have higher odds to attaining LDL-C goals and lower odds for attaining goals of HDL-C compared to males). Risk factors: T2DM = 1, no T2DM = 0, Having CHD = 1, No CHD = 0 (Example: having T2DM is associated with lower odds of attaining goal in any lipid parameter and having CHD is associated with lower odds of attaining goals in TC and LDL-C).